Textured Breast Implants Linked to Rare Form of Cancer Finally Recalled
This week the U.S. Food and Drug Administration finally requested that manufacturer Allergen issue a “voluntary” recall for its textured Biocell breast implants. The request comes two months after the FDA announced that despite having received a number of reports linking textured breast implants with a rare form of cancer known as anaplastic large cell lymphoma (ALCL) it would not remove the products from the U.S. market.